1. 1. Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol 6: 162-170, 2007.
2. 2. Tayer-Shifman OE, Seyahi E, Nowatzky J, Ben-Chetrit E. Major vessel thrombosis in Behçet's disease: the dilemma of anticoagulant therapy-the approach of rheumatologists from different countries. Clin Exp Rheumatol 30: 735-740, 2012.
3. 3. Emmi G, Silvestri E, Squatrito D, et al. Thrombosis in vasculitis: from pathogenesis to treatment. Thromb J 13: 15, 2015.
4. 4. Pengo V, Denas G, Zoppellaro G, et al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood 132: 1365-1371, 2018.
5. 5. Mader R, Ziv M, Adawi M, Mader R, Lavi I. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease. J Rheumatol 26: 2404-2408, 1999.